Search results
The most useful stem cell for tissue engineering and implantation for the treatment of OA are mesenchymal stem cells (MSCs). These are usually restricted to forming only mesodermal specific cell types (adipocytes, osteoblasts, myocytes, and chondrocytes), but several are able to differentiate into other cell varieties.
- Exploring Orthopedic Stem-Cell Approaches for Osteoarthritis Management ...
Adipose-derived mesenchymal stem cells (ADMSCs) have shown...
- Mesenchymal stem cell therapy in the treatment of hip osteoarthritis
The results presented in this clinical study, revealed that...
- Exploring Orthopedic Stem-Cell Approaches for Osteoarthritis Management ...
10 wrz 2024 · This systematic review aims to explore the potential of intra-articular mesenchymal stem cell (MSC) infiltrations as a therapeutic approach for hip OA. Following PRISMA guidelines, a systematic review was conducted, encompassing PubMed, Embase, and Cochrane Library databases.
14 gru 2019 · In this review, we discuss the biology of chondrogenesis, the stem cell populations that support articular cartilage in health and disease, and future opportunities afforded through the translation of basic articular chondrocyte stem cell biology into new clinical therapies. Significance statement.
Mesenchymal stem cells (MSCs) are a promising source for the treatment of OA due to their multipotency for differentiation into chondrocytes and their ability to modulate the immune system. Herein, we review the pathogenesis and treatment of OA and address the current status of MSCs as a novel potential therapeutic agent in OA treatment.
27 lis 2023 · Adipose-derived mesenchymal stem cells (ADMSCs) have shown promise in clinical trials for OA treatment, offering potential pain relief and functional improvement. ADMSCs possess advantages such as accessibility and a favorable safety profile, making them a viable option for OA management.
19 mar 2017 · The results presented in this clinical study, revealed that shortly after the intra articular infusion of a cell product consisting of ex vivo expanded autologous BM-MSC, an improvement in hip function occurred.
27 lis 2023 · Adipose-derived mesenchymal stem cells (ADMSCs) have shown promise in clinical trials for OA treatment, offering potential pain relief and functional improvement. ADMSCs possess advantages such as accessibility and a favorable safety profile, making them a viable option for OA management.
